This article is more than 5 years old. Information may no longer be current.

FTC approves Takeda’s Shire acquisition

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The U.S. Federal Trade Commission has approved Takeda Pharmaceutical’s acquisition of Shire, according to a press release.

The FTC issued an unconditional clearance of the takeover, which is still subject to other conditions, including other regulatory clearances and shareholder approval, the release said.

Takeda announced in May it would acquire Shire for approximately 46 billion pounds, or 49.01 pounds per Shire share.